
Organization · Family Office
Korify Capital
Korify Capital is a family office that invests in companies focused on longevity and mental health, targeting Series A to C funding rounds. They aim to support innovative teams and technologies in these sectors.
Overview
What Korify Capital does
What Korify Capital is
Korify Capital is a family office that invests in companies focused on longevity and mental health, targeting Series A to C funding rounds. They aim to support innovative teams and technologies in these sectors.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Family Office
- Structured capabilities
- Funder
- Last reviewed
- March 4, 2026
Official channels
Find Korify Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Korify Capital as a funder
Investment thesis
Korify Capital's investment thesis centers on breakthrough technologies in longevity and mental health, targeting companies that have demonstrated strong traction and proof of concept.
Focus narrative
Korify Capital invests in companies that are in Series A to C funding rounds. The organization targets companies that have demonstrated strong traction and proof of concept, positioning them as future leaders in their respective fields.
Focus and fit
- Stages
- Series A · Series B · Series C
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 3
Portfolio context
Notable portfolio companies include: Alto Neuroscience: Focuses on psychiatric drug development using AI-derived brain biomarkers to match patients with promising treatments. Cambrian: Develops therapeutics aimed at extending healthspan, the period of life spent in good health. Refoxy: Works on therapeutic medicines targeting age-related diseases, specifically through FOXO modulators.
Connected ecosystem
Continue from Korify Capital
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Common questions
What to know about Korify Capital
Upseed classifies Korify Capital under the Family Office organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.